Do Gene and Cell Therapies will Ultimately Replace Repeated Injections for the Treatment of Chronic Diseases

阅读量:

13

作者:

Shravana kumar Chinnikatti

展开

摘要:

Medical innovations are extremely important to be protected and exploited in an effective manner as they have strong social and economic impact. The potential of the gene editing tool CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) phenomenon seems to be the latest experimental use of the technology is creating skin grafts that trigger the release of insulin and help manage diabetes. This comes from the Research that has successfully tested the idea with mice that gained less weight and showed a reversed resistance to insulin because of the grafts [1]. I think this approach could eventually be used to treat a variety of metabolic and genetic conditions, not just diabetes it's a question of using skin cells to trigger different chemical reactions in the body because easy and abundantly available skin cells available at our disposal. This CRISPER is a new and innovative way of editing specific genes in the body which is responsible for a particular disease which is debilitating and by using a biological copy and paste technique: it can do everything from cut out HIV virus DNA to slow the growth of cancer cells and vice versa [2]. Any kind of disease where the body is deficient in specific molecules could potentially be targeted by this new technique. And if it works with diabetes, it could be time to say goodbye to needles and insulin injections. Any kind of disease where the body is deficient with specific molecules could potentially be targeted by this new technique. And if it works successfully with diabetes, it could be time to say goodbye to needles and insulin injections and also can be potentially be tried for the treatment of other disease like haemophilia and different cancers [3].

展开

DOI:

10.31031/OARA.2017.01.000509

年份:

2017

通过文献互助平台发起求助,成功后即可免费获取论文全文。

相似文献

参考文献

引证文献

研究点推荐

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用